Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€142.00
13.12.20
€170.00
13.12.21
9.00%
14.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Incyte Corp.

Start price
Target price
Perf. (%)
€67.64
24.02.21
-
24.02.22
-12.39%
25.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€50.00
15.03.22
43.43%
09.11.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€177.98
22.10.20
€170.00
04.11.21
-6.03%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€406.60
22.10.20
€580.00
04.11.21
37.09%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€85.17
14.08.20
€120.00
04.11.21
31.44%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
buy
Baxter International

Start price
Target price
Perf. (%)
€77.61
01.07.20
€80.00
04.11.21
-12.10%
05.11.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.87
08.06.20
€65.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.59
03.05.20
€90.00
04.11.21
-25.71%
05.11.21

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.31
30.04.20
€55.00
04.11.21
-24.47%
05.11.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.15
29.04.20
€90.00
04.11.21
-25.29%
05.11.21

buy
Centene Corp.

Start price
Target price
Perf. (%)
€63.00
28.04.20
€75.00
04.11.21
2.38%
05.11.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.99
24.04.20
€85.00
04.11.21
-21.03%
05.11.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.80
19.04.20
€80.00
04.11.21
-26.85%
05.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.04
17.03.20
€33.21
04.11.21
47.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€70.50
12.03.20
€145.00
04.11.21
119.55%
05.11.21

Could be worthwhile Investment >10% per year
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€117.78
11.03.20
€150.00
04.11.21
20.58%
05.11.21

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.02
22.02.20
€33.21
04.11.21
28.78%
05.11.21

buy
Incyte Corp.

Start price
Target price
Perf. (%)
€75.44
19.02.20
€100.00
04.11.21
-22.53%
05.11.21

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€127.44
17.01.20
€160.00
04.11.21
83.69%
05.11.21

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€83.00
22.12.19
€79.00
04.11.21
-3.61%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group